Collaborative discontinuation of antipsychotics after the first episode of psychosis.

Theo Korchia, Hani Abdelhafez, Alice Bretelle, Ridha Joober, Lena Palaniyappan
Author Information
  1. Theo Korchia: From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Abdelhafez, Joober, Palaniyappan); the Aix-Marseille University, Department of Psychiatry, Marseille, France (Korchia, Bretelle); the Robarts Research Institute, Western University, London, Ont. (Palaniyappan).
  2. Hani Abdelhafez: From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Abdelhafez, Joober, Palaniyappan); the Aix-Marseille University, Department of Psychiatry, Marseille, France (Korchia, Bretelle); the Robarts Research Institute, Western University, London, Ont. (Palaniyappan).
  3. Alice Bretelle: From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Abdelhafez, Joober, Palaniyappan); the Aix-Marseille University, Department of Psychiatry, Marseille, France (Korchia, Bretelle); the Robarts Research Institute, Western University, London, Ont. (Palaniyappan).
  4. Ridha Joober: From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Abdelhafez, Joober, Palaniyappan); the Aix-Marseille University, Department of Psychiatry, Marseille, France (Korchia, Bretelle); the Robarts Research Institute, Western University, London, Ont. (Palaniyappan).
  5. Lena Palaniyappan: From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Abdelhafez, Joober, Palaniyappan); the Aix-Marseille University, Department of Psychiatry, Marseille, France (Korchia, Bretelle); the Robarts Research Institute, Western University, London, Ont. (Palaniyappan).

Abstract

No abstract text available.

References

Early Interv Psychiatry. 2019 Feb;13(1):24-29 [PMID: 28524541]
Am J Psychiatry. 2022 Dec 1;179(12):938-946 [PMID: 36200276]
Soc Psychiatry Psychiatr Epidemiol. 2022 Jul;57(7):1329-1340 [PMID: 35041015]
Schizophr Res. 2018 May;195:231-236 [PMID: 29066258]
Schizophr Bull. 2021 Oct 21;47(6):1611-1620 [PMID: 34129663]
Am J Psychiatry. 2018 Aug 1;175(8):765-773 [PMID: 29621900]
Psychol Med. 2023 May;53(7):3085-3095 [PMID: 34937582]
Addict Behav Rep. 2022 Mar 17;15:100421 [PMID: 35434245]
Schizophr Bull. 2021 Jul 8;47(4):1116-1129 [PMID: 33754644]
J Ment Health. 2022 May 10;:1-9 [PMID: 35536145]
Cochrane Database Syst Rev. 2020 Aug 11;8:CD008016 [PMID: 32840872]
Neuropsychopharmacology. 2019 May;44(6):1036-1042 [PMID: 30514883]
Br J Psychiatry. 2017 Sep;211(3):137-143 [PMID: 28522434]
CNS Drugs. 2016 May;30(5):357-68 [PMID: 27106296]
BMC Psychiatry. 2013 May 29;13:153 [PMID: 23714262]
Br J Psychiatry. 2016 Nov;209(5):361-365 [PMID: 27802977]
Can J Psychiatry. 2017 Sep;62(9):604-616 [PMID: 28703015]

MeSH Term

Humans
Antipsychotic Agents
Psychotic Disorders
Treatment Outcome

Chemicals

Antipsychotic Agents

Word Cloud

Similar Articles

Cited By